47
Blackstone Life Sciences VI L.P. updates its Form D — $6.3B sold
Fund raise update · Private equity / buyout · Closed · Offering $6.3B · Sold $6.3B · NEW YORK, NY · filed 2026-04-02
3(c)(7) — qualified purchasers
Relevant to: Fund administrator, Fund audit & tax, Fund-formation counsel. Lead card pending.
| Nentcho G. Nentchev | Officer of the General Partner of the GP |
| n/a BXLS VI L.L.C. | The General Partner of the GP |
| Christopher G. Striano | Officer of the General Partner of the GP |
| Omar G. Rehman | Officer of the General Partner of the GP |
| John G. Finley | Officer of the General Partner of the GP |
| Tabea G. Hsi | Officer of the General Partner of the GP |
| Natacha G. Jamar | Officer of the General Partner of the GP |
| Joseph Baratta | Officer of the General Partner of the GP |
| n/a Blackstone Life Sciences Associates VI L.P. | "General Partner of the Issuer (the ""GP"")" |
| Julie Constable | Officer of the General Partner of the GP |
| Robert G. Liptak | Officer of the General Partner of the GP |
| Eric G. Liaw | Officer of the General Partner of the GP |
| Nicholas G. Galakatos | Officer of the General Partner of the GP |
| Elsa G. Gelin | Officer of the General Partner of the GP |
Signed by Julie Constable, Chief Compliance Officer.
Placement agents / sales compensation: Raymond James & Associates, Inc.; Compass Group Global Advisors S.A.; Raymond James Financial Services Inc.
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.